October 27, 2014
A New York federal judge threw out Apotex Inc.'s case accusing Acorda Therapeutics Inc. of making false and misleading statements about its multiple sclerosis drug Zanaflex, finding in a ruling last week that Apotex failed to offer evidence showing Acorda's statements would influence consumers' purchasing decisions.